Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Collaborative research has shown a new vaccine developed by researchers at The Jenner Institute at the University of Oxford is effective at protecting pregnant sheep and goats from Rift Valley fever (RVF).
Bayer Animal Health has signed up Spanish start-up VLPbio in a partnership focused on strengthening the former's portfolio of biological products.
Austria's Erber Group has added another animal health company to its portfolio with the capture of Brazilian firm IPEVE.
An unnamed industry partner of Spanish firm Algenex has submitted a veterinary vaccine for European centralized approval.
Indian firm Hester Biosciences claims the current financial predicament faced by the United Nations (UN) will not have a knock-on effect on its Nepalese business.
Boehringer Ingelheim Animal Health has completed the expansion of its R&D and manufacturing plant in Athens, Georgia.
Data, predictive models and vaccination delivery are key emerging innovation trends in the livestock sector, according to a panel of experts.
Quickly implementing a foot-and-mouth disease (FMD) vaccine bank is key to minimizing the impact of any outbreak of the disease in the US.
Boehringer Ingelheim Animal Health has received authorization from the European Medicines Agency (EMA) for Reprocyc ParvoFLEX – its new porcine parvovirus (PPV) vaccine.
Ceva Santé Animale has added to its poultry vaccine R&D capabilities by signing an exclusive license with German firm ProBioGen.
Roslin Technologies, the Moredun Research Institute, Scotland's Rural College and the Roslin Institute are collaborating to fund the commercial development of an E coli vaccine.
Industry body Animal Medicines Australia (AMA) has voiced disapproval of the decision by the country's government to introduce a board to the Australian Pesticides and Veterinary Medicines Authority (APVMA).
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.